GlassScriptPhysician profile
Kyle C Lange
NPI 1629503032
$4,428.25
in general payments reported to CMS, 2019-2025
19 companies · $830 in 2025
The $830 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $15.39 · 2023: $97.51 · 2024: $3,486 · 2025: $830.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,500 · Food and Beverage: $1,119 · Travel and Lodging: $470 · Long Term Medical Supply Or Device Loan: $325.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,500.00 |
| Food and Beverage | $1,118.53 |
| Travel and Lodging | $469.72 |
| Long Term Medical Supply Or Device Loan | $324.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,259.12 | 2024-2025 | |
| Integra Lifesciences Corporation | $421.36 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $145.78 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Acera Surgical, INC. | $123.60 | 2024-2025 | Restrata Wound Matrix |
| Vertex Pharmaceuticals Incorporated | $86.53 | 2025 | |
| Haemonetics Corporation | $57.47 | 2023-2024 | Teg6s Hemostasis System |
| Teleflex LLC | $49.41 | 2023-2025 | Quikclot, Quikclot |
| Atricure, INC. | $47.06 | 2024-2025 | Atricure Cryoice Cryoablation System (Cryo2), Atricure Cryoice Cryosphere Cryoablation System |
| Boston Scientific Corporation | $37.86 | 2024 | Spyglass Discover |
| Octapharma USA, INC. | $25.86 | 2024 | Balfaxar |
| Cerus Corporation | $24.53 | 2023 | Intercept Blood System For Platelets |
| Lifenet Health | $22.35 | 2025 | Theragenesis Wound Matrix |
| Solventum Corporation | $22.25 | 2025 | Prevena, Abthera Advance |
| Convatec INC. | $21.25 | 2024 | |
| Abbott Laboratories | $20.36 | 2024 | I-Stat |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $17.14 | 2024 | Ovitex 2s |
| La Jolla Pharmaceutical Company | $16.38 | 2025 | Giapreza |
| Davol INC. | $15.39 | 2022 | |
| Prytime Medical Devices, INC. | $14.55 | 2025 | Er-Reboa Plus |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Lange listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.